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Cytotoxic Activity of ent-Cyclozonarone
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A síntese completa da mistura racêmica do cyclozonarone ((±)-3), foi obtida a partir do E,E-
farnesol (4) em uma seqüência de oito passos com um rendimento geral de 6,6%. O albicanol 
((±)-1) e seu acetato ((±)-2) são intermediários. Uma seqüência inicial, similar a partir do produto 
natural (-)-drimenol (5), produziu o(+)-albicanol (1) e o(+)-cyclozonarone (3) com 42% e 11%, 
respectivamente. A atividade citotóxica do composto(+)-cyclozonarone foi avaliada e mostrou 
alguma seletividade para MS-1 (células endoteliais de camundongos).
The total synthesis of racemic cyclozonarone ((±)-3) was achieved from E,E-farnesol (4)
in an eight-step sequence in 6.6% overall yield. Albicanol ((±)-1) and its acetate ((±)-2) are 
intermediates. A similar sequence starting from natural (-)-drimenol (5) gave (+)-albicanol (1) and 
(+)-cyclozonarone (3) (42% and 11% yield, respectively). The cytotoxic activity of (+)-cyclozonarone 
was assayed and showed some selectivity towards MS-1 (mice endothelial cells).
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Introduction
Synthetic efforts towards naturally occurring drimane 
sesquiterpenes have been constant due to their interesting 
biological activities.
The drimane-type alcohol albicanol ((+)-1) (Figure 1) 
was isolated from the liverworts Diplophyllum albilcans1
and later from the dorid nudibranch Cadlina luteomarginata
together with its acetate ((+)-2) which has a potent fish 
antifeedant activity.2
Banerjee3,4 has previously synthesized racemic albicanol 
in an eight-step sequence, in 13% yield, starting from a 
drimane keto alcohol, which in turn has to be prepared by 
a several-step route, in 58% yield, from a commercially 
available octalone.5,6 The total synthesis of racemic (1)
and (2) had already been accomplished, as well, by Weiler7
through electrophilic cyclization of alkenic alkylsilanes, by 
a short three-step sequence in 30% yield, as a mixture of 
 and  isomers in C-9. Several asymmetric approaches 
to chiral 1 and 2 have been reported;8-12 starting from 
higher terpenes with the trans decaline feature already 
constructed, such as manool, 8 or by routes involving optical 
resolution9-11 and/or diasteroselective key steps, as reported 
by Shishido.12
Natural (-)-cyclozonarone (3) (Figure 1) has been 
isolated by Kurata et al.13 from the Pacific brown algae 
Dictyopteris undulata and possesses a potent feeding-
deterrent activity toward young abalones. We have 
previously established the absolute configuration of natural 
(-)-(5R,10R)-cyclozonarone ((-)-3) through a six-step 
route, starting from natural (-)-polygodial, leading us to the 
synthetic enantiomer (+)-(5S,10S)-cyclozonarone ((+)-3).14
Later, (-)-cyclozonarone (3) was synthesized by Seifert 
et al.15 starting from (+)-albicanol (1), which in turn was 
prepared in 9 steps from -ionone.16
Results and Discussion
Our strategy started with E,E-farnesol where the 
cyclization of 4 led to (±)-drimenol (5) according to 
Welzel’s procedure; Scheme 1.17 Acetylation of drimenol 
((±)-5) was performed as usually using Ac
2
O and pyridine. 
The key step of the synthesis was the selenocatalytic allylic 
chlorination of drimenyl acetate ((±)-6);18 leading to an 
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inseparable mixture of two chlorinated epimers (7a and
7b) which was subjected to reduction with Zinc dust, to 
furnish racemic albicanyl acetate ((±)-2) and unchanged 
- chlorinated epimer ((±)-7b). Treatment of the previous 





(±)-1 and (±)-8 which were isolated and characterised by 
spectroscopic data analysis. 
The more concluding data to establish (±)-8 as the 
7- -chlorinated epimer, was the double doublet centred 
at 1.95 ppm for H-5, the constants (J 3.1 and 9.1 Hz) are 
corresponding to axial-equatorial and axial-axial couplings 
with each H-6. The signal centred at 2.29 ppm for H-6 eq 
(ddd, J 2.6, 5.0 and 12.6 Hz) evidenced an axial-equatorial 
coupling with H-5 and H-7ax, besides the geminal coupling. 
Moreover, the coupling constants for H-7 (signal centred 
at 4.35 ppm) suggest an axial disposition for this proton. 
Thus, confirming the equatorial disposition for the chloro 
atom in (±)-8. On the basis of a similar analysis for H-5, 
H-6 and H-7 on both chlorinated albicanyl acetate (7a and 
7b) the major epimer was assumed to have an axial chloro 
in C-7, while the minor epimer should correspond to the 
equatorial chloro in C-7. 
The lack of reactivity for the equatorial chloro epimer 
towards Zn could be attributed to esteric hindrance for 
effective overlapping. Nevertheless, the ability of 7b to 
react with Zn was confirmed submitting a sample of pure 
7b to the same experimental conditions as the epimeric 
mixture, although the reaction seems to be slower. 
The possibility of readily preparing diene 9 from 
(±)-1 prompted us to assay a different approach to 
(±)-cyclozonarone. (±)-Albicanol (1) was dissolved in 
pyridine and added to a mixture of Tf
2
O in pyridine, the 
reaction yielded 62% of diene 9. Racemic cyclozonarone 
was obtained from (±)-9 and benzoquinone as previously 
described14 (Scheme 2). Since racemic drimenol ((±)-5) has 
been previously resolved in its enantiomers19 the sequence 
described represents a formal synthesis of both enantiomers 
of cyclozonarone.
Starting from natural (-)-drimenol (5), 20 (+)-albicanol 1
and ent-cyclozonarone ((+)-3) were also prepared following 
the same sequence depicted in Schemes 1 and 2.
Our continuous interest in synthetic methods for 
cyclozonarone is grounded in the biological activities 
both enantiomers exhibit. Previously, the effect of ent-
cyclozonarone ((+)-3), prepared in these laboratories, on 
the growth of T. cruzi epimastigotes, Tulahuen strains, 
was studied together with that of the reference drugs 
nifurtimox and benznidazole (made by Roche under the 
trade names Radanil™, Rochagan™ or Roganil™).21
Compound (+)-3 resulted ten times more active than the 
reference drugs. Recently, we have assayed cytotoxic 
Figure 1. (+)-Albicanol (1), (+)-albicanyl acetate (2), cyclozonarone 
((-)- 3) and ent-cyclozonarone ((+)-3).






(5:1), -78°C, 1 h, 52% for (±)-5; (b) Ac
2
O, Py, r.t. 91% for (±)-6; 86% for 




, r.t., 3 h, 69% (for the 
epimeric mixture 7a and 7b) from (±)-6; 71% ( for the epimeric mixture 
7a and 7b) from (+)-6; (d) Zn dust, HOAc, THF, H
2





, r.t. 4 h, 71% (calculated from the epimeric mixture) for (±)-1
after isolation from (±)-8; 69% (calculated from the epimeric mixture) 
for (+)-1 after isolation from (-)-8.
Synthesis of Racemic and Chiral Albicanol, Albicanyl Acetate and Cyclozonarone J. Braz. Chem. Soc.1260
activity of ent-cyclozonarone against cell lines A-549 
(human lung carcinoma), HT-29 (human colon carcinoma), 
H-116 (human colon carcinoma), MS-1 (mice endothelial 
cells) and PC-3 (human prostate carcinoma), following the 
method reported by Bergeron et al.22 The IC 50 obtained for 
the five mentioned cell lines are shown in Table 1, resulting 
that the activity against MS-1 cells is 10-50 times higher 
than towards other cell lines tested.
Conclusions
Here, we have described a short total synthesis of 
racemic albicanol ((±)-1) (five steps, in 23% yield) and 
cyclozonarone ((±)-3) (eight steps, in 6.6% overall yield), 
starting from commercially available E,E farnesol. The 
key steps are the protonic cyclization of farnesol and the 
selenocatalytic allylic chlorination of drimenyl acetate 
((±)-6)18 to accomplish double bond isomerization. A 
similar sequence starting from natural (-)-drimenol (5) gave 
enantiopure (+)-1 and (+)-3 (42% and 11% respectively). 
Moreover, we have tested ent-cyclozonarone cytotoxic 
activity obtaining interesting IC50 values against all the 




Melting points were determined on a Stuart Scientific 
SMP3 apparatus and are uncorrected. IR spectra were 
recorded on a Bruker Vector 22-FT in KBr disc or film. 
Optical rotations were obtained for CHCl
3
 solutions in an 
Optical Activity, Ltd instrument in a 1 dm cell and their 
concentrations are expressed in g per mL. NMR spectra 
were recorded on a Bruker AC 200P (200.13 MHz for 1H,
50.13 MHz for 13C) in CDCl
3
 solutions with TMS as internal 
standard. Carbon multiplicity was established by a DEPT 
pulse sequence and signals were assigned based on 2D 
experiments. All two-dimension spectra were acquired with 
a Bruker AVANCE 400 Spectrometer with a Bruker inverse 
5 mm Z gradient probe. The HMBC spectra were obtained 
using the inv4gplrndqf pulse sequence in the Bruker 
software. HRMS were determined on a MAT 95XP, Thermo 
Finnigan spectrometer. Chromatographic separations were 
carried out on Merck silica gel 60 (230-400 Mesh) using 
hexane-ethylacetate gradients of increasing polarity. All 
organic extracts were dried over magnesium sulfate and 




F (0.08 mL, 1.35 mmol) was added, at –78 ºC, 
to a solution of (E,E)-farnesol (4) (300 mg, 1.35 mmol) 




, 12:1 (13 mL). After 







N (0.25 mL), diluted with water and extracted with 
EtOAc. The organic phase was dried (MgSO
4
), filtered 
and the solvent was removed by simple distillation. The 
product was purified by column chromatography (hexane/
EtOAc 8:2) to give (±)-5 (156 mg, 52%) as a colourless 
oil. Spectroscopic characteristics (NMR) being identical 
to those of natural (-)-drimenol; IR (KBr)
max
/cm-1:






Figure 2. Significant coupling constants for (±)-8, characterised as 
7 -chloro epimer.
Scheme 2. Reagents and conditions. (a) Tf
2
O, Py, 0ºC r.t., 40 min., 62% 
for (±)-9 (mixture of endo and exo dienes 1:4); 60% for enantiopure 9
(mixture of endo and exo dienes 1:4); (b) p-benzoquinone, Bz, reflux, 
28 h; (c) DDQ, reflux, 4 h, 46%, 2 steps (from (±)-9 for (±)-3); 45%, 2 
steps (for ent-cyclozonarone (+)-3).
Table 1. Cytotoxic activity of ent-cyclozonarone (+)-(11)
Compound A 549 HT 29 H 116 MS 1 PC 3
(+)-(11) IC
50
 /( g mL-1) 5-1 1 5 0.5-0.1 5
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(±)- Drimenyl acetate (6)
A mixture of (±)-5 (474 mg, 2.1 mmol), pyridine (5 mL) 
and acetic anhydride (0.2 mL, 2.5 mmol) was stirred for 
3 h at room temperature. The mixture was diluted with 
H
2
O and extracted with EtOAc. The organic phase was 





) and the solvent was evaporated. The residue was 
purified by column chromatography to afford (±)-6 (513 
mg, 91%) as a colourless oil, with identical spectroscopic 
characteristics as previously described for (+)-drimenyl 
acetate from natural (-)-drimenol.23
7  and 7 -chloro-albicanyl acetate ((±)-7a and (±)-7b)
Drimenyl acetate (±)-6 (262 mg, 0.99 mmol) was added to 
a solution of commercially available phenylselenyl chloride 




 (6 mL). N-chlorosuccinimide 




 (5 mL) was added to the 
previously prepared mixture. After stirring for 2 h at room 
temperature, the solvent was removed and the residue was 
suspended in diethyl ether. The organic layer was decanted 
from the solid, washed with H
2
O and brine, dried (MgSO
4
)
and the solvent was removed under reduced pressure. The 
resulting crude was purified by column chromatography 
to afford an inseparable C-7 epimeric mixture of (±)-7a 
and (±)-7b (204 mg, 69%). Signals assignable to the major 
epimer: 1H NMR (CDCl
3
, 400 MHz)  0.74 (s, 3H), 0.80 (s, 
3H), 0.87 (s, 3H), 2.02 (s, CH
3
COO, 3H), 2.60-2.66 (ddd, 
J 1.9 Hz, J 3.8 Hz and J 8.7 Hz, 1H), 4.09-4.19 (dd, J 8.7 
Hz and J 11.3 Hz, 1H, H-11), 4.31-4.39 (dd, J 3.9 Hz and J
11.3 Hz,1H, H-11), 4.72 (d, J 1.7 Hz,1H, H-12), 4.84-4.87 
( dd, J 2.8 Hz, 1H, H-7), 5.15 ( d, J 1.7 Hz, 1H, H-12); 13C
NMR (CDCl
3
, 100 MHz)  33.4 (CH
2





, C-3), 32.9 (C, C-4), 47.4 (CH, C-5), 41.7 (CH
2
,
C-6), 65.5 (CH, C-7), 145.6 (C, C-8), 49.0 (CH, C-9), 38.7 
(C, C-10), 60.9 (CH
2
, C-11), 111.6 (CH
2





, C-14), 14.6 (CH
3





COO). Signals assignable to the minor 
epimer: 1H NMR (CDCl
3
, 400 MHz)  0.78 (s, 3H), 0.83 (s, 
3H), 0.92 (s, 3H), 2.02 (s, CH
3
COO, 3H), 2.24-2.34 (ddd, 
J 2.5 Hz, J 5.1 Hz and J 12.5 Hz, 1H, H-6eq), 4.08-4.26 ( 
dd, J 5.0 Hz and J 12.3 Hz, 1H, H-7), 4.17-4.27 ( dd, J 9.1 
Hz and J 11.2 Hz, 1H, H-11), 4.33-4.82 ( dd, J 4.0 Hz and J
11.2 Hz,1H, H-11), 4.83 (d, J 1.4,1H, H-12), 5.51 (d, J 1.4, 
1H, H-12); 13C NMR (CDCl
3





, C-2), 38.6 (CH
2
, C-3), 33.6 (C, C-4), 54.6 (CH, 
C-5)*, 41.7 (CH
2
, C-6), 63.5 (CH, C-7), 144.1 (C, C-8), 54.9 
(CH, C-9)*, 38.7 (C, C-10), 61.1 (CH
2





, C-13), 21.1 (CH
3
, C-14), 15.1 (CH
3
, C-15), 




COO). *Signals may 
be interchanged. HRMS (M+) (mixture of epimers) Found: 








Zn dust (433 mg, 6.62 mmol) was added to a solution 
of the mixture of epimers (±)-7 (241 mg, 0.81 mmol) in 
HOAc (4.05 mL), THF (5.6 mL) and H
2
O (2.3 mL). This 
mixture was stirred at room temperature for 6 h. The 
solution was diluted with diethyl ether and the organic 
phase was decanted from the solid, washed with saturated 
NaHCO
3
 aqueous solution, water and dried (MgSO
4
); the 
solvent was removed under reduced pressure. After column 
chromatography on silica gel, 192 mg of an inseparable 
mixture of albicanyl acetate ((±)-2) and the  chlorinated 





/ MeOH and usual work up, gave after 
column chromatography 40 mg of 7 -chloro-albicanol 
((±)-8); 1H NMR (CDCl
3
, 400 MHz)  0.73 (s, 3H), 0.80 
(s, 3H), 0.90 (s, 3H), 1.05-1.65 (m, 8H, H-1, H-2, H-3, 
H-6ax and H-9), 1.94-1.97 (dd, J 3.1 Hz and J 9.1 Hz, 1H, 
H-5), 2.26-2.32 (ddd, J 2.6 Hz, J 5.0 Hz and J 12.6 Hz, 1H, 
H-6eq), 3.80-3.85 (dd, J 8.1 Hz and J 10.3 Hz, 1H, H-11), 
3.87-3.91 ( dd, J 3.7 Hz and J 10.3 Hz, 1H, H-11), 4.33-
4.37 (dd, J 5.0 Hz and J 12.6 Hz, 1H, H-7ax), 4.92 (bs, 1H, 





, C-1), 19.0 (CH
2
, C-2), 41.7 (CH
2
, C-3), 33.6 
(C, C-4), 58.8 (CH, C-5), 36.1 (CH
2
, C-6), 63.6 (CH, C-7), 





, C-12), 33.4 (CH
3





, C-15) and 128 mg (71% from mixture of 
epimers 7) of (±)-albicanol (1); mp 68.2-68.8 ºC (hexane) 
(lit2 mp 68-69 ºC); 1H NMR (CDCl
3
, 200 MHz)  0.69 (s, 
3H), 0.78 (s, 3H), 0.85 (s, 3H), 1.94-2.04 (m, 2H, H-7ax, 
H-9), 2.38-2.45 ( ddd, J 2.4 Hz, J 4.2 Hz and J 12.9 Hz, 
1H, H-7eq), 3.70-3.76 (d, J 11.0 Hz, 1H, H-11), 3.80-3.87 
(dd, J 4.0 Hz and J 11.0 Hz, 1H, H-11), 4.64 (d, J 1.7 Hz, 
1H, H-12), 4.94 (d, J 1.7 Hz, 1H, H-12); 13C NMR (CDCl
3
,
50 MHz)  39.1 (CH
2
, C-1), 19.2 (CH
2
, C-2), 41.9 (CH
2
,
C-3), 33.5 (C, C-4), 55.2 (CH, C-5), 24.2 (CH
2
, C-6), 37.9 
(CH
2
, C-7), 147.9 (C, C-8), 59.1 (CH, C-9), 39.0 (C, C-10), 
58.8 (CH
2
, C-11), 106.3 (CH
2





, C-14), 15.3 (CH
3
, C-15). HRMS (M+) Found : 






(±)-Albicanol (1) was acetylated as described for 
(±)-drimenol to give 220 mg (83%) of (±)-2 as an oil 
with identical spectroscopic characteristics as previously 
described for natural (+)-albicanyl acetate.2 HRMS (M+)







Diene (±)-(9). A solution of triflic anhydride (0.22 mL) 
in pyridine was added dropwise to a solution of albicanol 
((±)-1) (63 mg, 0.3 mmol) in pyridine (10 mL) at 0 ºC. 
The mixture was stirred for 40 min at room temperature. 
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An ice-water mixture was added and the solution was 
neutralized with NaHCO
3
 and extracted with ethyl ether. 
The organic layer was dried (MgSO
4
) and the solvent was 
removed in vacuum. The crude was purified by column 
chromatography to afford an oily product (38 mg, 62%) 
as a mixture of endo and exo dienes (1:4). Spectral data of 
the major isomer is in good agreement with those reported 
for exo-diene (9).14
(±)-Cyclozonarone (3)
Benzoquinone (27.5 mg, 0.25 mmol) was added to a 
solution of diene (±)-9 (1:4 mixture of endo and exo dienes) 
(40 mg, 0.19 mmol) in benzene (10 mL) and the mixture 
was refluxed under N
2
 atmosphere for 28 h. The solvent 
was removed under reduced pressure and the residue was 
purified by column chromatography to afford 21 mg of 
quinone 10, which was eluted after the unchanged endo-
diene. Quinone 10 was dissolved in benzene (10 mL) 
and DDQ (15 mg, 0.062 mmol) was added. The mixture 
was refluxed for 4 h and after removing the solvent 
under reduced pressure and column chromatography, 
(±)-cyclozanorone (3) 18.2 mg, (46% overall yield 
from (±)-9) was obtained as a yellow oil, with identical 
spectroscopic characteristics as previously described for 
natural (-)-cyclozonarone.13 The same protocol was used 
for the synthesis of (+)-cyclozonarone (3) starting from 
natural (-)-drimenol.20
(+)-Drimenyl acetate (+)-6
Acetylation of (-)-drimenol (1.5 g, 6.76 mmol) using 
standard condition furnished drimenyl acetate as colourless 
oil (1.53 g, 86%). Physical and spectroscopic characteristics 
were in good agreement with those previously described.23
[ ]28
D
+ 7.69 (c 5.2, CHCl
3
).
7  and 7 -chloro-albicanyl acetate (7a and 7b)
Allylic chlorination of (+)-drimenyl acetate (200 mg,
0.09 mmol) gave an inseparable mixture of 7  and 
7 -chloro-albicanyl acetate (7a and 7b) (160.2 mg, 







/cm-1 (KBr pellets): 1731, 1241, 918, 












O of 7 (mixture of 
epimers) (106 mg, 0.36 mmol) afforded 77 mg of a mixture 
of albicanyl acetate ((+)-2) and unchanged 7 -chloro-
albicanyl acetate (7b), as an oil. Isolation by preparative 
TLC afforded 53 mg (66.3 %) of (+)-albicanyl acetate (2);
[ ]22
D




/cm-1 (film KBr): 
2928, 1740, 1235 ; and 23mg ( 28.8 % ) of unchanged 
7 -chloro-albicanyl acetate ((+)-7b); [ ]22
D





/cm-1 (KBr pellets): 2942, 1731, 
1240, 907.
(+)-Albicanol (+)-1
Saponification of the reduction mixture (250 mg) 
followed by column chromatography gave 170 mg of 
(+)-albicanol (1) as colourless needles; mp 67.5-68.3 ºC 
(lit2 mp 68-69 ºC); [ ]22
D
 + 9.1º (c 2.21, CHCl
3
) (lit2 [ ]25
D
+ 13.0º (c 0.5, CHCl
3





O: 222.19836; IR 
max
/cm-1 (KBr pellets): 
3371, 2941, 1691, 1644, 880; and 7- -chlorol-albicanol
((-)-8) (52 mg) as colourless needles; mp 89.7-91.6 ºC; 
[ ]28
D
 – 2.8º (c 3.6, CHCl
3
); IR (KBr): 
max
/cm-1 3265, 
2925, 1650, 1460. 
Diene (9)
Dehydration of (+)-albicanol (1) (94.1 mg, 0.42 mmol) 
afforded 52 mg, (60%) of diene 9 (mixture of exo and endo
diene 1:4) as an oily product. Spectral data of the major 
isomer is in good agreement with those formerly reported 
by us for exo-diene (9).14
(+)-Ent-cyclozonarone
Diels Alder reaction of diene mixture (52 mg, 
0.25 mmol) with p-benzoquinone (35.13 mg, 0.33 mmol) 
followed by oxidation of the corresponding quinone with 
DDQ (27.4 mg, 0.12 mmol) gave (+)-ent-cyclozonarone 
(35.3 mg, 45%) as oil. IR(KBr): 
max
/cm-1 2924, 1669, 1600, 
1460; 1H-NMR and 13C NMR spectra identical to those of 
natural (-)-cyclozonarone.13
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Figure S1. 1H NMR for albicanyl acetate (+)-2.
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Figure S2. 13C NMR for albicanyl acetate (+)-2.
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Figure S3. 1H NMR for albicanol (+)-1.
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Figure S4. 13C NMR for albicanol (+)-1.
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Figure S5. 1H NMR for diene 9 (endo:exo / 1:4).
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Figure S6. 13C NMR for diene 9 (endo:exo / 1:4).
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Figure S7. 1H NMR and 13C-NMR for ent-cyclozonarone (+)-3.
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Figure S8. 1H NMR for 7  and 7 -chloro-albicanyl acetate (±)-7a and (±)-7b.
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Figure S9. 1H NMR for (+)-7b (unchanged epimer after 7  +7  reduction with Zn).
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Figure S10. 13C DEPT for (+)-7b.
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Figure S11. 1H NMR for 7 -chloro-albicanol (-)-8.
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Figure S12. 3D structure for 7 -chloro-albicanyl acetate.
Figure S13. 3D structure for 7 -chloro-albicanyl acetate.
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Figure S14. 3D structure for 7 -chloro-albicanol.
